Ignite Creation Date:
2024-05-06 @ 2:33 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04358458
Status:
TERMINATED
Last Update Posted:
2023-09-21
First Post:
2020-04-01
Brief Title:
First-in-Human FIH Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Sponsor:
Genmab
Organization:
Genmab
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Mediastinal Large B-cell Lymphoma |
| Diffuse Large B-cell Lymphoma |
| Follicular Lymphoma |
| Marginal Zone Lymphoma |
| Small Lymphocytic Lymphoma |
| Mantle Cell Lymphoma |
| Chronic Lymphocytic Leukemia |
| High-grade B-cell Lymphoma |
Keywords:
| Name | View |
|---|---|
| Anti-CD37 monoclonal antibodies DuoHexabody | View |